好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Extending The Clinical Spectrum of Dejerine Sottas Syndrome: A new Family With Cognitive Impairment And Hearing Loss Carrying Trembler Mutation
General Neurology
P1 - Poster Session 1 (5:30 PM-6:30 PM)
4-048

To report a new Dejerine-Sottas phenotype in a family carrying Trembler mouse mutation.

Dejerine-Sottas syndrome is a severe hereditary neuropathy with heterogeneous genetic transmission. Both autosomal dominant and autosomal recessive inheritance patterns have been described.

Only one report of a mother and son with Dejerine-Sottas syndrome carrying the mutation gly150asp in the Gene PMP22 has been previously reported in 1997. This exact mutation is found in the Trembler mouse used to study Charcot-Marie-Tooth disease (CMT).

Case series

A 43-year-old woman  presented with gross ataxia which started in her childhood. She stopped walking at age 10 and has been wheelchair-bound since adolescence. Neurological examination revealed profound sensory ataxia and hearing loss as well as mild cognitive impairment. Nerve conduction studies revealed severe sensorimotor  neuropathy. Genetic testing results showed she was heterozygous for point mutation mutation gly150asp in PMP22 gene. Her 20 year old son has a similar phenotype and was carrying the same mutation. He is currently uses crutches for ambulation.

 

In addition to severe peripheral neuropathy, both the mother and son were found to have cognitive impairment and hearing loss. It is worth noting that neither the cognitive impairment nor the hearing loss were reported in the 1997 case. This report extends the clinical spectrum of Dejerine-Sottas Syndrome to involve the central nervous system and cranial nerves.

 

Authors/Disclosures
Soumya Bouchachi, MD (OSU)
PRESENTER
Dr. Bouchachi has nothing to disclose.
Nizar Souayah, MD, FAAN (NJMS) Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.